7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Low E et al. | Expression of mRNA for osteoprotegerin and receptor activator of nuclear factor kappa beta ligand (RANKL) during root resorption induced by the application of heavy orthodontic forces on rat molars. | 2005 | Am J Orthod Dentofacial Orthop | pmid:16214633 |
Taddei SR et al. | Role of CCR2 in orthodontic tooth movement. | 2012 | Am J Orthod Dentofacial Orthop | pmid:22284282 |
Enhos S et al. | OPG and RANKL levels around miniscrew implants during orthodontic tooth movement. | 2013 | Am J Orthod Dentofacial Orthop | pmid:23910201 |
Yabumoto T et al. | Stabilization of tooth movement by administration of reveromycin A to osteoprotegerin-deficient knockout mice. | 2013 | Am J Orthod Dentofacial Orthop | pmid:23992809 |
Lim WH et al. | Downregulation of Wnt causes root resorption. | 2014 | Am J Orthod Dentofacial Orthop | pmid:25172256 |
Kuang B et al. | Combined degenerative and regenerative remodeling responses of the mandibular condyle to experimentally induced disordered occlusion. | 2013 | Am J Orthod Dentofacial Orthop | pmid:23273362 |
Flórez-Moreno GA et al. | Time-related changes in salivary levels of the osteotropic factors sRANKL and OPG through orthodontic tooth movement. | 2013 | Am J Orthod Dentofacial Orthop | pmid:23273364 |
Kuczkowski J et al. | Expression of the receptor activator for nuclear factor-κB ligand and osteoprotegerin in chronic otitis media. | 2010 Nov-Dec | Am J Otolaryngol | pmid:20015790 |
Røysland R et al. | Prognostic value of osteoprotegerin in chronic heart failure: The GISSI-HF trial. | 2010 | Am. Heart J. | pmid:20691834 |
Mogelvang R et al. | Comparison of osteoprotegerin to traditional atherosclerotic risk factors and high-sensitivity C-reactive protein for diagnosis of atherosclerosis. | 2012 | Am. J. Cardiol. | pmid:22100028 |
Akat K et al. | Calcium metabolism in adults with severe aortic valve stenosis and preserved renal function. | 2010 | Am. J. Cardiol. | pmid:20211333 |
Dahl JS et al. | Relation of osteoprotegerin in severe aortic valve stenosis to postoperative outcome and left ventricular function. | 2013 | Am. J. Cardiol. | pmid:23871267 |
Abedin M et al. | Relation of osteoprotegerin to coronary calcium and aortic plaque (from the Dallas Heart Study). | 2007 | Am. J. Cardiol. | pmid:17293196 |
Schnabel RB et al. | Relation of multiple inflammatory biomarkers to incident atrial fibrillation. | 2009 | Am. J. Cardiol. | pmid:19576326 |
Erkol A et al. | Relation of circulating osteoprotegerin levels on admission to microvascular obstruction after primary percutaneous coronary intervention. | 2011 | Am. J. Cardiol. | pmid:21247537 |
Van Campenhout A et al. | Serum osteoprotegerin as a biomarker for vascular disease. | 2007 | Am. J. Cardiol. | pmid:17659953 |
Shen C et al. | Relation between bone mineral density, bone loss and the risk of cardiovascular disease in a Chinese cohort. | 2012 | Am. J. Cardiol. | pmid:22762713 |
Shea MK et al. | Vitamin K supplementation and progression of coronary artery calcium in older men and women. | 2009 | Am. J. Clin. Nutr. | pmid:19386744 |
Shea MK et al. | Vitamin K, circulating cytokines, and bone mineral density in older men and women. | 2008 | Am. J. Clin. Nutr. | pmid:18689371 |
Roux S et al. | RANK (receptor activator of nuclear factor kappa B) and RANK ligand are expressed in giant cell tumors of bone. | 2002 | Am. J. Clin. Pathol. | pmid:11863217 |
Sato T et al. | Interleukin-11 as an osteoprotegerin-inducing factor in culture medium of blastic cells from a patient with acute megakaryocytic leukemia complicated with osteosclerosis. | 2004 | Am. J. Hematol. | pmid:15307108 |
Elhasid R et al. | Familial severe congenital neutropenia associated with infantile osteoporosis: a new entity. | 2003 | Am. J. Hematol. | pmid:12508266 |
Nuño-Arana I et al. | Distribution of three SNPs related to low bone mineral density in Amerindian groups and Mestizos from Mexico. | 2012 Jul-Aug | Am. J. Hum. Biol. | pmid:22434650 |
Canto-Cetina T et al. | Polymorphism of LRP5, but not of TNFRSF11B, is associated with a decrease in bone mineral density in postmenopausal Maya-Mestizo women. | 2013 Nov-Dec | Am. J. Hum. Biol. | pmid:24130145 |
Guerrini MM et al. | Human osteoclast-poor osteopetrosis with hypogammaglobulinemia due to TNFRSF11A (RANK) mutations. | 2008 | Am. J. Hum. Genet. | pmid:18606301 |
Hocking LJ et al. | Genomewide search in familial Paget disease of bone shows evidence of genetic heterogeneity with candidate loci on chromosomes 2q36, 10p13, and 5q35. | 2001 | Am. J. Hum. Genet. | pmid:11555792 |
Zagura M et al. | Association of osteoprotegerin with aortic stiffness in patients with symptomatic peripheral artery disease and in healthy subjects. | 2010 | Am. J. Hypertens. | pmid:20224558 |
Noheria A et al. | Association of serum osteoprotegerin with left ventricular mass in African American adults with hypertension. | 2010 | Am. J. Hypertens. | pmid:20339356 |
Ye Z et al. | Associations of candidate biomarkers of vascular disease with the ankle-brachial index and peripheral arterial disease. | 2013 | Am. J. Hypertens. | pmid:23467205 |
Golledge J et al. | A single-nucleotide polymorphism in the gene encoding osteoprotegerin is associated with diastolic blood pressure in older men. | 2009 | Am. J. Hypertens. | pmid:19779468 |
Nitta K et al. | The progression of vascular calcification and serum osteoprotegerin levels in patients on long-term hemodialysis. | 2003 | Am. J. Kidney Dis. | pmid:12900812 |
Coen G et al. | Serum leptin in dialysis renal osteodystrophy. | 2003 | Am. J. Kidney Dis. | pmid:14582047 |
Nitta K et al. | Effects of cyclic intermittent etidronate therapy on coronary artery calcification in patients receiving long-term hemodialysis. | 2004 | Am. J. Kidney Dis. | pmid:15384019 |
Fukagawa M et al. | Skeletal resistance to pth as a basic abnormality underlying uremic bone diseases. | 2001 | Am. J. Kidney Dis. | pmid:11576943 |
Sato T et al. | Osteoprotegerin levels before and after renal transplantation. | 2001 | Am. J. Kidney Dis. | pmid:11576949 |
Kazama JJ et al. | Increased circulating levels of osteoclastogenesis inhibitory factor (osteoprotegerin) in patients with chronic renal failure. | 2002 | Am. J. Kidney Dis. | pmid:11877571 |
Haas M et al. | Osteoprotegerin and parathyroid hormone as markers of high-turnover osteodystrophy and decreased bone mineralization in hemodialysis patients. | 2002 | Am. J. Kidney Dis. | pmid:11877577 |
Gottesman GS et al. | Auricular ossification: A newly recognized feature of osteoprotegerin-deficiency juvenile Paget disease. | 2016 | Am. J. Med. Genet. A | pmid:26762549 |
Kantaputra PN et al. | A newly recognized polyosteolysis/hyperostosis syndrome. | 2006 | Am. J. Med. Genet. A | pmid:17001672 |
Tanaka S | Signaling axis in osteoclast biology and therapeutic targeting in the RANKL/RANK/OPG system. | 2007 | Am. J. Nephrol. | pmid:17652963 |
Mazzaferro S et al. | Serum levels of calcification inhibition proteins and coronary artery calcium score: comparison between transplantation and dialysis. | 2007 | Am. J. Nephrol. | pmid:17259697 |
Cozzolino M et al. | Vascular calcification and uremia: what do we know? | 2008 | Am. J. Nephrol. | pmid:18046081 |
Nishiura R et al. | Elevated osteoprotegerin levels predict cardiovascular events in new hemodialysis patients. | 2009 | Am. J. Nephrol. | pmid:18802328 |
Lewis JR et al. | Elevated osteoprotegerin predicts declining renal function in elderly women: a 10-year prospective cohort study. | 2014 | Am. J. Nephrol. | pmid:24457210 |
Cianciolo G et al. | Importance of vascular calcification in kidney transplant recipients. | 2014 | Am. J. Nephrol. | pmid:24819032 |
Bersinger NA et al. | PAPP-A and osteoprotegerin, together with interleukin-8 and RANTES, are elevated in the peritoneal fluid of women with endometriosis. | 2006 | Am. J. Obstet. Gynecol. | pmid:16635455 |
Rhee EJ et al. | The effects of C161-->T polymorphisms in exon 6 of peroxisome proliferator-activated receptor-gamma gene on bone mineral metabolism and serum osteoprotegerin levels in healthy middle-aged women. | 2005 | Am. J. Obstet. Gynecol. | pmid:15846185 |
Hong JS et al. | Maternal plasma osteoprotegerin concentration in normal pregnancy. | 2005 | Am. J. Obstet. Gynecol. | pmid:16157103 |
Kawai T et al. | B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease. | 2006 | Am. J. Pathol. | pmid:16936272 |
Ohishi M et al. | Osteoprotegerin abrogated cortical porosity and bone marrow fibrosis in a mouse model of constitutive activation of the PTH/PTHrP receptor. | 2009 | Am. J. Pathol. | pmid:19389927 |
Redlich K et al. | Repair of local bone erosions and reversal of systemic bone loss upon therapy with anti-tumor necrosis factor in combination with osteoprotegerin or parathyroid hormone in tumor necrosis factor-mediated arthritis. | 2004 | Am. J. Pathol. | pmid:14742260 |
Biosse-Duplan M et al. | Histamine promotes osteoclastogenesis through the differential expression of histamine receptors on osteoclasts and osteoblasts. | 2009 | Am. J. Pathol. | pmid:19264900 |
Yan J et al. | Bone marrow ablation demonstrates that excess endogenous parathyroid hormone plays distinct roles in trabecular and cortical bone. | 2012 | Am. J. Pathol. | pmid:22640808 |
de Hooge AS et al. | Adenoviral transfer of murine oncostatin M elicits periosteal bone apposition in knee joints of mice, despite synovial inflammation and up-regulated expression of interleukin-6 and receptor activator of nuclear factor-kappa B ligand. | 2002 | Am. J. Pathol. | pmid:12000725 |
Lacey DL et al. | Osteoprotegerin ligand modulates murine osteoclast survival in vitro and in vivo. | 2000 | Am. J. Pathol. | pmid:10934148 |
Lawrie A et al. | Paigen diet-fed apolipoprotein E knockout mice develop severe pulmonary hypertension in an interleukin-1-dependent manner. | 2011 | Am. J. Pathol. | pmid:21835155 |
Samee N et al. | Dlx5, a positive regulator of osteoblastogenesis, is essential for osteoblast-osteoclast coupling. | 2008 | Am. J. Pathol. | pmid:18669617 |
Huang L et al. | Gene expression of osteoprotegerin ligand, osteoprotegerin, and receptor activator of NF-kappaB in giant cell tumor of bone: possible involvement in tumor cell-induced osteoclast-like cell formation. | 2000 | Am. J. Pathol. | pmid:10702390 |
Secchiero P et al. | An increased osteoprotegerin serum release characterizes the early onset of diabetes mellitus and may contribute to endothelial cell dysfunction. | 2006 | Am. J. Pathol. | pmid:17148684 |
Lawrie A et al. | Evidence of a role for osteoprotegerin in the pathogenesis of pulmonary arterial hypertension. | 2008 | Am. J. Pathol. | pmid:18156213 |
Romas E et al. | Osteoprotegerin reduces osteoclast numbers and prevents bone erosion in collagen-induced arthritis. | 2002 | Am. J. Pathol. | pmid:12368214 |
Sato K et al. | RANKL synthesized by both stromal cells and cancer cells plays a crucial role in osteoclastic bone resorption induced by oral cancer. | 2013 | Am. J. Pathol. | pmid:23499553 |
Wilkison M et al. | Type 1 interferons suppress accelerated osteoclastogenesis and prevent loss of bone mass during systemic inflammatory responses to Pneumocystis lung infection. | 2012 | Am. J. Pathol. | pmid:22626807 |
Steagall WK et al. | Osteoprotegerin contributes to the metastatic potential of cells with a dysfunctional TSC2 tumor-suppressor gene. | 2013 | Am. J. Pathol. | pmid:23867796 |
Grimaud E et al. | Receptor activator of nuclear factor kappaB ligand (RANKL)/osteoprotegerin (OPG) ratio is increased in severe osteolysis. | 2003 | Am. J. Pathol. | pmid:14578201 |
Simionescu A et al. | Osteogenic responses in fibroblasts activated by elastin degradation products and transforming growth factor-beta1: role of myofibroblasts in vascular calcification. | 2007 | Am. J. Pathol. | pmid:17591959 |
Mancini L et al. | Calcitonin and prednisolone display antagonistic actions on bone and have synergistic effects in experimental arthritis. | 2007 | Am. J. Pathol. | pmid:17322385 |
Dela Cruz A et al. | Elevated Gα11 expression in osteoblast lineage cells promotes osteoclastogenesis and leads to enhanced trabecular bone accrual in response to pamidronate. | 2016 | Am. J. Physiol. Endocrinol. Metab. | pmid:27006198 |
Cawley NX et al. | Obese carboxypeptidase E knockout mice exhibit multiple defects in peptide hormone processing contributing to low bone mineral density. | 2010 | Am. J. Physiol. Endocrinol. Metab. | pmid:20460579 |
Wang L et al. | Targeted overexpression of G protein-coupled receptor kinase-2 in osteoblasts promotes bone loss. | 2005 | Am. J. Physiol. Endocrinol. Metab. | pmid:15585587 |
Piemontese M et al. | Cortical bone loss caused by glucocorticoid excess requires RANKL production by osteocytes and is associated with reduced OPG expression in mice. | 2016 | Am. J. Physiol. Endocrinol. Metab. | pmid:27460899 |
Vidal K et al. | Osteoprotegerin production by human intestinal epithelial cells: a potential regulator of mucosal immune responses. | 2004 | Am. J. Physiol. Gastrointest. Liver Physiol. | pmid:15521102 |
Olesen P et al. | Calcification of human vascular smooth muscle cells: associations with osteoprotegerin expression and acceleration by high-dose insulin. | 2007 | Am. J. Physiol. Heart Circ. Physiol. | pmid:17056676 |
Rashid G et al. | Parathyroid hormone decreases endothelial osteoprotegerin secretion: role of protein kinase A and C. | 2009 | Am. J. Physiol. Renal Physiol. | pmid:18945829 |
Frick KK et al. | RANK ligand and TNF-alpha mediate acid-induced bone calcium efflux in vitro. | 2005 | Am. J. Physiol. Renal Physiol. | pmid:15972386 |
Ragab AA et al. | Cytokines synergistically induce osteoclast differentiation: support by immortalized or normal calvarial cells. | 2002 | Am. J. Physiol., Cell Physiol. | pmid:12176725 |
Villa I et al. | CGRP inhibits osteoprotegerin production in human osteoblast-like cells via cAMP/PKA-dependent pathway. | 2006 | Am. J. Physiol., Cell Physiol. | pmid:16611736 |
Pacifici R | Osteoimmunology and its implications for transplantation. | 2013 | Am. J. Transplant. | pmid:23915249 |
Bargnoux AS et al. | Evolution of coronary artery calcifications following kidney transplantation: relationship with osteoprotegerin levels. | 2009 | Am. J. Transplant. | pmid:19775319 |
Byron CR et al. | In vitro expression of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in cultured equine articular cells. | 2010 | Am. J. Vet. Res. | pmid:20513175 |
Ferrer Cañabate J et al. | [Osteoprotegrin and RANKL/RANK system: is it the future of bone metabolism?]. | 2002 | An Med Interna | pmid:12244784 |
Bloch SL et al. | The viability of perilabyrinthine osteocytes: a quantitative study using bulk-stained undecalcified human temporal bones. | 2012 | Anat Rec (Hoboken) | pmid:22577084 |
Sun Z and Tee BC | Molecular variations related to the regional differences in periosteal growth at the mandibular ramus. | 2011 | Anat Rec (Hoboken) | pmid:21157918 |
Shiotani A et al. | Regulation of osteoclast differentiation and function by receptor activator of NFkB ligand and osteoprotegerin. | 2002 | Anat. Rec. | pmid:12221720 |
Oshiro T et al. | Osteoclast induction in periodontal tissue during experimental movement of incisors in osteoprotegerin-deficient mice. | 2002 | Anat. Rec. | pmid:11920384 |
McGonigle JS et al. | Osteoprotegerin and RANKL differentially regulate angiogenesis and endothelial cell function. | 2009 | Angiogenesis | pmid:19105036 |
Benslimane-Ahmim Z et al. | Mechanistic study of the proangiogenic effect of osteoprotegerin. | 2013 | Angiogenesis | pmid:23386104 |
Mori K et al. | Effects of pravastatin on serum osteoprotegerin levels in patients with hypercholesterolemia and type 2 diabetes. | 2010 Feb-Mar | Angiology | pmid:19147525 |
Shaker OG et al. | Possible role of osteoprotegerin and tumor necrosis factor-related apoptosis-inducing ligand as markers of plaque instability in coronary artery disease. | 2010 | Angiology | pmid:20498140 |
Koshikawa M et al. | Elevated osteopontin levels in patients with peripheral arterial disease. | 2009 Feb-Mar | Angiology | pmid:18388057 |
Toygar HU et al. | Osteoprotegerin in gingival crevicular fluid under long-term continuous orthodontic force application. | 2008 | Angle Orthod | pmid:18947279 |
Tan L et al. | Osteoprotegerin and ligand of receptor activator of nuclear factor kappaB expression in ovariectomized rats during tooth movement. | 2009 | Angle Orthod | pmid:19216604 |
Borsje MA et al. | Comparison of low-intensity pulsed ultrasound and pulsed electromagnetic field treatments on OPG and RANKL expression in human osteoblast-like cells. | 2010 | Angle Orthod | pmid:20050743 |
Yu H et al. | Overexpression of osteoprotegerin promotes preosteoblast differentiation to mature osteoblasts. | 2011 | Angle Orthod | pmid:20936961 |
Xu Y et al. | Regulation of the response of the adult rat condyle to intermaxillary asymmetric force by the RANKL-OPG system. | 2009 | Angle Orthod | pmid:19537860 |
Rody WJ et al. | Differences in the gingival crevicular fluid composition between adults and adolescents undergoing orthodontic treatment. | 2014 | Angle Orthod | pmid:23687969 |
Barbieri G et al. | Biochemical markers of bone metabolism in gingival crevicular fluid during early orthodontic tooth movement. | 2013 | Angle Orthod | pmid:22716279 |
Jin Y et al. | Functional role of mechanosensitive ion channel Piezo1 in human periodontal ligament cells. | 2015 | Angle Orthod | pmid:24810489 |
Telejko B et al. | The association of bone turnover markers with pro- and anti-inflammatory adipokines in patients with gestational diabetes. | 2015 | Ann Agric Environ Med | pmid:26094529 |
Liu J et al. | Pressure-loaded MSCs during early osteodifferentiation promote osteoclastogenesis by increase of RANKL/OPG ratio. | 2009 | Ann Biomed Eng | pmid:19148752 |